Monomethyl auristatin E Exhibits Potent Cytotoxic Activity against Human Cancer Cell Lines SKBR3 and HEK293
<h2>Background: Monomethyl auristatin E (MMAE) is a synthetic analog of dolastatin 10, a compound originally isolated from the marine mollusk. MMAE, as a highly potent microtubule inhibitor, exerts its potent cytotoxic effect by inhibiting microtubule assembly, tubulin-dependent GTP hydrolysis...
Main Authors: | Meghdad Abdollahpour-Alitappeh, Sepand Razavi-vakhshourpour, Majid Lotfinia, Saeed Jahandideh, Hamid Najminejad, Saeed Balalaie, Reza Moazzami, Elnaz Shams, Mahdi Habibi-Anbouhi, Mohsen Abolhassani |
---|---|
Format: | Article |
Language: | English |
Published: |
Shahid Beheshti University of Medical Sciences
2017-10-01
|
Series: | Novelty in Biomedicine |
Subjects: | |
Online Access: | http://journals.sbmu.ac.ir/nbm/article/view/15221 |
Similar Items
-
Monomethyl Auristatin E, a Potent Cytotoxic Payload for Development of Antibody-Drug Conjugates against Breast Cancer
by: Meghdad Abdollahpour-alitappeh, et al.
Published: (2017-06-01) -
Monomethyl Auristatin E Grafted-Liposomes to Target Prostate Tumor Cell Lines
by: Ariana Abawi, et al.
Published: (2021-04-01) -
Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy
by: Hanhee Cho, et al.
Published: (2022-10-01) -
Whole-Body Pharmacokinetics and Physiologically Based Pharmacokinetic Model for Monomethyl Auristatin E (MMAE)
by: Hsuan Ping Chang, et al.
Published: (2021-03-01) -
A Conjugate Based on Anti-HER2 Diaffibody and Auristatin E Targets HER2-Positive Cancer Cells
by: Anna M. Serwotka-Suszczak, et al.
Published: (2017-02-01)